The Latest

Join scientists from around the world, September 21-23, in Málaga, Spain, for Science Summit 2026: Networked for Life: Nuclear Receptors in Age-related Diseases. Abstract submission for this upcoming Science Summit is now closed. Presenting authors should expect to hear back regarding the status of their abstract in late-July. To view a review your submission or to print a confirmation, log in to the Abstract Submission Site.

Are you ready for ABIM’s Endocrinology, Diabetes, and Metabolism Certification Exam? With over a decade of experience, we are confident that our program will help you succeed on this test and enhance your clinical critical thinking skills. Your registration includes a printed copy of the Endocrine Board Review (2026) 18th Edition Book, interactive practice exams, and live study sessions with experts.

Prepare with confidence using the Endocrine Board Review, 18th Edition, the trusted resource for fellows and endocrinologists. With more than 220 case-based questions aligned to the ABIM exam blueprint, it keeps your study focused and efficient. Pre-order now to get ahead, with early access to the interactive practice exam in July and receive your hard copy in August.

Thank you to all the attendees, speakers, and sponsors who participated in ENDO 2026! Visit our wrap-up page to find helpful links and instructions on such things as claiming credits, session recordings, certificates of attendance, and more. See you next year, June 5-8, for ENDO 2027 in Toronto, ON, Canada!

This Thematic Issue comprises articles coauthored by speakers scheduled to present at ENDO 2026. These articles cover a wide range of cutting-edge topics in endocrinology and were all published by Endocrine Society Journals within the last year.

Host Aaron Lohr talks with Dennis M. Black, PhD, from the University of California, San Francisco, Richard Eastell, MBChB, PhD, FRCP, FMedSci, from the University of Sheffield, and Mary L. Bouxsein, PhD, from Harvard Medical School about the SABRE Project and its significant impact on osteoporosis clinical trials. This episode was inspired by the work of the Endocrine Society Bone and Mineral Special Interest Group.

Host Chase Hendrickson, MD, MPH, MHCC, from Vanderbilt University, talks with regular contributor Amal Shibli Rahhal, MD, from the University of Iowa, and guest expert Thomas Weber, MD, from Duke Health. Together, they discuss “Anti-fracture efficacy of 5 or 10 yearly zoledronate in women aged 50 to 60 years,” published in the April 2026 issue of JCEM, and consider how these findings may inform decisions around early treatment strategies, risk assessment, and long-term fracture prevention in clinical practice.